Innate immunity to adenovirus

Human Gene Therapy

Volumn 25, Issue 4, 2014, Pages 265-284

  Hendrickx, Rodinde ^a   Stichling, Nicole ^a   Koelen, Jorien ^b   Kuryk, Lukasz ^c   Lipiec, Agnieszka ^d   Greber, Urs F ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Oncos Therapeutics Inc   (Finland)

^d Bioscience Park Leiden   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA DEFENSIN; BETA DEFENSIN; BETA INTERFERON; BLOOD CLOTTING FACTOR 10; DNA DIRECTED RNA POLYMERASE III; E1A PROTEIN; E1B PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 8; LECTIN RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; DNA; INTERFERON;

ADAPTIVE IMMUNITY; ADENOVIRUS; AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; AUTOPHAGY; DNA PACKAGING; GENE EXPRESSION; HOST CELL; HOST RESISTANCE; HUMAN; HUMAN ADENOVIRUS 1; HUMAN ADENOVIRUS 2; HUMAN ADENOVIRUS 5; INFLAMMATION; INNATE IMMUNITY; LIVER; NONHUMAN; OLIGOMERIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTION; VIRUS REPLICATION; CYTOSOL; GENE THERAPY; GENE VECTOR; GENETICS; HOST PATHOGEN INTERACTION; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; CYTOSOL; DNA; GENETIC THERAPY; GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERONS; SIGNAL TRANSDUCTION; VIRUS INTERNALIZATION;

EID: 84899100555     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.001     Document Type: Review

References (281)

1. Ablasser, A., Goldeck, M., and Cavlar, T., et al. (2013a). cGAS produces a 2¢-5¢-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380-384.
2. Ablasser, A., Schmid-Burgk, J.L., Hemmerling, I., et al. (2013b). Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503, 530-534.
3. Ackrill, A.M., Foster, G.R., Laxton, C.D., et al. (1991). Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19, 4387-4393. (Pubitemid 21912814)
4. Agol, V.I. (2012). Cytopathic effects: virus-modulated manifestations of innate immunity? Trends Microbiol. 20, 570-576.
5. Akusjarvi, G., Mathews, M.B., Andersson, P., et al. (1980). Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc. Natl. Acad. Sci. USA 77, 2424-2428.
6. Amstutz, B., Gastaldelli, M., Kälin, S., et al. (2008). Subversion of CtBP1 controlled macropinocytosis by human Adenovirus serotype 3. EMBO J. 27, 956-966.
7. Appledorn, D.M., Patial, S., Mcbride, A., et al. (2008). Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181, 2134-2144.
8. Arcasoy, S.M., Latoche, J., Gondor, M., et al. (1997). MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells. Am. J. Respir. Cell Mol. Biol. 17, 422-435. (Pubitemid 127500975)
9. Arnberg, N. (2012). Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol. Sci. 33, 442-448.
10. Aste-Amezaga, M., Bett, A.J., Wang, F., et al. (2004). Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum. Gene Ther. 15, 293-304. (Pubitemid 38365918)
11. Barlan, A.U., Danthi, P., and Wiethoff, C.M. (2011a). Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology 412, 306-314.
12. Barlan, A.U., Griffin, T.M., Mcguire, K.A., et al. (2011b). Adenovirus membrane penetration activates the NLRP3 inflammasome. J. Virol. 85, 146-155.
13. Basner-Tschakarjan, E., Gaffal, E., O'keeffe, M., et al. (2006). Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J. Gene Med. 8, 1300-1306. (Pubitemid 44782509)
14. Bauernfeind, F., and Hornung, V. (2013). Of inflammasomes and pathogens-sensing of microbes by the inflammasome. EMBO Mol. Med. 5, 814-826.
15. Berhane, S., Areste, C., Ablack, J.N., et al. (2011). Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1. Virology 421, 149-158.
16. Berk, A.J. (1986). Adenovirus promoters and E1A transactivation. Annu. Rev. Genet. 20, 45-79.
17. Beutler, B., Jiang, Z., Georgel, P., et al. (2006). Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24, 353-389.
18. Bhattacharya, S., Eckner, R., Grossman, S., et al. (1996). Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383, 344-347. (Pubitemid 26321765)
19. Bjørkøy, G., Lamark, T., Brech, A., et al. (2005). p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603-614. (Pubitemid 41668720)
20. Bowman, E.J., Siebers, A., and Altendorf, K. (1988). Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85, 7972-7976.
21. Bradshaw, A.C., Parker, A.L., Duffy, M.R., et al. (2010). Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog. 6, e1001142.
22. Bremner, K.H., Scherer, J., Yi, J., et al. (2009). Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 6, 523-535.
23. Bruder, J.T., and Kovesdi, I. (1997). Adenovirus infection stimulates the Raf/Mapk signaling pathway and induces interleukin-8 expression. J. Virol. 71, 398-404. (Pubitemid 26412305)
24. Buck, C.B. (2008). Defensins' offensive play: exploiting a viral achilles' heel. Cell Host Microbe 3, 3-4.
25. Buck, C.B., Day, P.M., Thompson, C.D., et al. (2006). Human alpha-defensins block papillomavirus infection. Proc. Natl. Acad. Sci. USA 103, 1516-1521. (Pubitemid 43191197)
26. Buckland, F.E., and Tyrrell, D.A. (1963). A comparative study of virus haemagglutinins. The stability of haemagglutinins and red cell receptors to certain physical and chemical treatments. J. Gen. Microbiol. 32, 241-253.
27. Burckhardt, C.J., and Greber, U.F. (2009). Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog. 5, e1000621.
28. Burckhardt, C.J., Suomalainen, M., Schoenenberger, P., et al. (2011). Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 10, 105-117.
29. Burdeinick-Kerr, R., Wind, J., and Griffin, D.E. (2007). Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J. Virol. 81, 5628-5636. (Pubitemid 46847002)
30. Burgert, H.G., Ruzsics, Z., Obermeier, S., et al. (2002). Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol. Immunol. 269, 273-318. (Pubitemid 34851538)
31. Carlisle, R.C., Di, Y., Cerny, A.M., et al. (2009a). Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood 113, 1909-1918.
32. Carlisle, R.C., Di, Y., Cerny, A.M., et al. (2009b). Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood 113, 1909-1918.
33. Carlisle, R., Choi, J., Bazan-Peregrino, M., et al. (2013). Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound. J. Natl. Cancer Inst. 1701-1710.
34. Carson, C.T., Orazio, N.I., Lee, D.V., et al. (2009). Mislocalization of the MRN complex prevents ATR signaling during adenovirus infection. EMBO J. 28, 652-662.
35. Carvalho, T., Seeler, J.S., Ohman, K., et al. (1995). Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrixassociated PML bodies. J. Cell Biol. 131, 45-56.
36. Cerliani, J.P., Stowell, S.R., Mascanfroni, I.D., et al. (2011). Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity. J. Clin. Immunol. 31, 10-21.
37. Cerullo, V., Seiler, M., Mane, V., et al. (2007). Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 15, 378-385. (Pubitemid 46111889)
38. Chahal, J.S., and Flint, S.J. (2012). Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells. J. Virol. 86, 3064-3072.
39. Chahal, J.S., Qi, J., and Flint, S.J. (2012). The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells. PLoS Pathog. 8, e1002853.
40. Chahal, J.S., Gallagher, C., Dehart, C.J., et al. (2013). The repression domain of the E1B 55-kilodalton protein participates in countering interferon-induced inhibition of adenovirus replication. J. Virol. 87, 4432-4444.
41. Cheng, P.H., Lian, S., Zhao, R., et al. (2013). Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells. Virol. J. 10, 293.
42. Chiu, Y.H., Macmillan, J.B., and Chen, Z.J. (2009). RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576-591.
43. Cianciola, N.L., and Carlin, C.R. (2009). Adenovirus RID-alpha activates an autonomous cholesterol regulatory mechanism that rescues defects linked to Niemann-Pick disease type C. J. Cell Biol. 187, 537-552.
44. Cianciola, N.L., Greene, D.J., Morton, R.E., et al. (2013). Adenovirus RIDalpha uncovers a novel pathway requiring ORP1L for lipid droplet formation independent of NPC1. Mol. Biol. Cell. 24, 3309-3325.
45. Cichon, G., Boeckh-Herwig, S., Schmidt, H.H., et al. (2001). Complement activation by recombinant adenoviruses. Gene Ther. 8, 1794-1800. (Pubitemid 34100580)
46. Crooks, D., Kil, S.J., Mccaffery, J.M., et al. (2000). E3-13.7 integral membrane proteins encoded by human adenoviruses alter epidermal growth factor receptor trafficking by interacting directly with receptors in early endosomes. Mol. Biol. Cell 11, 3559-3572.
47. Croyle, M.A., Chirmule, N., Zhang, Y., et al. (2001). "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75, 4792-4801. (Pubitemid 32381522)
48. Daher, K.A., Selsted, M.E., and Lehrer, R.I. (1986). Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60, 1068-1074. (Pubitemid 17179284)
49. Danthi, P. (2011). Enter the kill zone: initiation of death signaling during virus entry. Virology 411, 316-324.
50. Davies, B.W., Bogard, R.W., Young, T.S., et al. (2012). Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 149, 358-370.
51. Dechecchi, M.C., Melotti, P., Bonizzato, A., et al. (2001). Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75, 8772-8780. (Pubitemid 32768981)
52. Dechecchi, M.C., Tamanini, A., Bonizzato, A., et al. (2000). Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268, 382-390. (Pubitemid 30159987)
53. De Geest, B., Snoeys, J., Van Linthout, S., et al. (2005). Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone. Hum. Gene Ther. 16, 1439-1451. (Pubitemid 41829019)
54. Deretic, V., Jiang, S., and Dupont, N. (2012). Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 22, 397-406.
55. Di Paolo, N.C., Doronin, K., Baldwin, L.K., et al. (2013). The transcription factor IRF3 triggers "defensive suicide" necrosis in response to viral and bacterial pathogens. Cell Rep. 3, 1840-1846.
56. Doronin, K., Flatt, J.W., Di Paolo, N.C., et al. (2012). Coagulation factor X activates innate immunity to human species C adenovirus. Science 338, 795-798.
57. Dupont, N., Jiang, S., Pilli, M., et al. (2011). Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1. Eur. Mol. Biol. Organ. J. 30, 4701-4711.
58. Echavarria, M. (2008). Adenoviruses in immunocompromised hosts. Clin. Microbiol. Rev. 21, 704-715.
59. Engelke, M.F., Burckhardt, C.J., Morf, M.K., et al. (2011). The dynactin complex enhances the speed of microtubule-dependent motions of adenovirus both towards and away from the nucleus. Viruses 3, 233-253.
60. Evans, J.D., and Hearing, P. (2003). Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J. Virol. 77, 5295-5304. (Pubitemid 36460943)
61. Evans, J.D., and Hearing, P. (2005). Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 79, 6207-6215. (Pubitemid 40617225)
62. Ewer, K.J., O'hara, G.A., Duncan, C.J., et al. (2013). Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat. Commun. 4, 2836.
63. Faure, M., and Rabourdin-Combe, C. (2011). Innate immunity modulation in virus entry. Curr. Opin. Virol. 1, 6-12.
64. Fejer, G., Drechsel, L., Liese, J., et al. (2008). Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog. 4, e1000208.
65. Fejer, G., Freudenberg, M., Greber, U.F., et al. (2011). Adenovirus triggered innate signalling pathways. Eur. J. Microbiol. Immunol. 1, 279-288.
66. Ferguson, B.J., Mansur, D.S., Peters, N.E., et al. (2012). DNAPK is a DNA sensor for IRF-3-dependent innate immunity. eLife 1, e00047.
67. Ferrari, R., Pellegrini, M., Horwitz, G.A., et al. (2008). Epigenetic reprogramming by adenovirus E1a. Science 321, 1086-1088.
68. Ferreon, A.C., Ferreon, J.C., Wright, P.E., et al. (2013). Modulation of allostery by protein intrinsic disorder. Nature 498, 390-394.
69. Fink, S.L., and Cookson, B.T. (2005). Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907-1916. (Pubitemid 40470787)
70. Flatt, J.W., Kim, R., Smith, J.G., et al. (2013). An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS ONE 8, e61571.
71. Fleischli, C., Verhaagh, S., Havenga, M., et al. (2005). The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35. J. Virol. 79, 10013-10022. (Pubitemid 41022342)
72. Flint, S.J., and Gonzalez, R.A. (2003). Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins. Curr. Top. Microbiol. Immunol. 272, 287-330. (Pubitemid 36458332)
73. Fonseca, G.J., Thillainadesan, G., Yousef, A.F., et al. (2012). Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 11, 597-606.
74. Fonseca, G.J., Cohen, M.J., Nichols, A.C., et al. (2013). Viral retasking of hBre1/RNF20 to recruit hPaf1 for transcriptional activation. PLoS Pathog. 9, e1003411.
75. Frisch, S.M., and Mymryk, J.S. (2002). Adenovirus-5 E1A: paradox and paradigm. Nat. Rev. Mol. Cell Biol. 3, 441-452. (Pubitemid 34685701)
76. Gaggar, A., Shayakhmetov, D.M., and Lieber, A. (2003). CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9, 1408-1412. (Pubitemid 37466191)
77. Ganz, T., Selsted, M.E., Szklarek, D., et al. (1985). Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76, 1427-1435. (Pubitemid 16193690)
78. Gao, D., Wu, J., Wu, Y.T., et al. (2013). Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906.
79. Gastaldelli, M., Imelli, N., Boucke, K., et al. (2008). Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 9, 2265-2278.
80. Gazzola, M., Burckhardt, C.J., Bayati, B., et al. (2009). A stochastic model for microtubule motors describes the in vivo cytoplasmic transport of human adenovirus. PLoS. Comp. Biol. 5, e1000623.
81. Geijtenbeek, T.B., Van Vliet, S.J., Engering, A., et al. (2004). Self-and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22, 33-54. (Pubitemid 38680417)
82. Gongora, R., Stephan, R.P., Zhang, Z., et al. (2001). An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons. Immunity 14, 727-737. (Pubitemid 32592420)
83. Greber, U.F. (2002). Signalling in viral entry. Cell Mol. Life Sci. 59, 608-626. (Pubitemid 34457539)
84. Greber, U.F., and Way, M. (2006). A super highway to virus infection. Cell 124, 741-754.
85. Greber, U.F., Willetts, M., Webster, P., et al. (1993). Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75, 477-486. (Pubitemid 23335073)
86. Greber, U.F., Singh, I., and Helenius, A. (1994). Mechanisms of virus uncoating. Trends Microbiol 2, 52-56. (Pubitemid 24051422)
87. Greber, U.F., Webster, P., Weber, J., et al. (1996). The role of the adenovirus protease on virus entry into cells. EMBO J. 15, 1766-1777. (Pubitemid 26119212)
88. Greber, U.F., Arnberg, N., Wadell, G., et al. (2013). Adenoviruses-from pathogens to therapeutics: a report on the 10th International Adenovirus Meeting. Cell Microbiol. 15, 16-23.
89. Green, N.K., Hale, A., Cawood, R., et al. (2012). Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer. Nanomedicine (Lond) 7, 1683-1695.
90. Gutch, M.J., and Reich, N.C. (1991). Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88, 7913-7917. (Pubitemid 21915265)
91. Haisma, H.J., and Bellu, A.R. (2011). Pharmacological interventions for improving adenovirus usage in gene therapy. Mol. Pharm. 8, 50-55.
92. Hall, K., Blair Zajdel, M.E., and Blair, G.E. (2009). Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells. Virology 392, 222-229.
93. Hamasaki, M., Furuta, N., Matsuda, A., et al. (2013). Autophagosomes form at ER-mitochondria contact sites. Nature 495, 389-393.
94. Harrach, B., Benkö, M., Both, G., et al. (2011). Adenoviridae-Ninth report of the International Committee on Taxonomy of Viruses. In Virus Taxonomy. A. King, M. Adams, E. Carstens, and E. Lefkowitz, eds. (Elsevier, Oxford), pp 125-141.
95. Hartman, Z.C., Black, E.P., and Amalfitano, A. (2007a). Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358, 357-372. (Pubitemid 46136424)
96. Hartman, Z.C., Kiang, A., Everett, R.S., et al. (2007b). Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J. Virol. 81, 1796-1812. (Pubitemid 46214453)
97. Harui, A., Suzuki, S., Kochanek, S., et al. (1999). Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73, 6141-6146. (Pubitemid 29274908)
98. Hauler, F., Mallery, D.L., Mcewan, W.A., et al. (2012). AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc. Natl. Acad. Sci. USA 109, 19733-19738.
99. Heemskerk, B., Lankester, A.C., Van Vreeswijk, T., et al. (2005). Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J. Infect. Dis. 191, 520-530. (Pubitemid 40216667)
100. Heise, C., Hermiston, T., Johnson, L., et al. (2000). An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6, 1134-1139.
101. Helmuth, J.A., Burckhardt, C.J., Koumoutsakos, P., et al. (2007). A novel supervised trajectory segmentation algorithm identifies distinct types of human adenovirus motion in host cells. J. Struct. Biol. 159, 347-358. (Pubitemid 47348297)
102. Hemmi, S., Vidovszky, M.Z., Ruminska, J., et al. (2011). Genomic and phylogenetic analyses of murine adenovirus 2. Virus Res. 160, 128-135.
103. Hofherr, S.E., Shashkova, E.V., Weaver, E.A., et al. (2008). Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol. Ther. 16, 1276-1282. (Pubitemid 351866059)
104. Hornung, V., Ablasser, A., Charrel-Dennis, M., et al. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518.
105. Horwitz, M.S. (2004). Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. J. Gene Med. 6 Suppl 1, S172-S183. (Pubitemid 40228026)
106. Horwitz, G.A., Zhang, K., Mcbrian, M.A., et al. (2008). Adenovirus small e1a alters global patterns of histone modification. Science 321, 1084-1085.
107. Iacobelli-Martinez, M., and Nemerow, G.R. (2007). Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J. Virol. 81, 1305-1312. (Pubitemid 46167851)
108. Iacobelli-Martinez, M., Nepomuceno, R.R., Connolly, J., et al. (2005). CD46-utilizing adenoviruses inhibit C/EBPbetadependent expression of proinflammatory cytokines. J. Virol. 79, 11259-11268. (Pubitemid 41170668)
109. Imelli, N., Ruzsics, Z., Puntener, D., et al. (2009). Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol. J. 6, 174.
110. Ishikawa, H., and Barber, G.N. (2008). STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678.
111. Jager, S., Bucci, C., Tanida, I., et al. (2004). Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 117, 4837-4848. (Pubitemid 39433449)
112. Janeway, C.A., and Medzhitov, R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20, 197-216. (Pubitemid 34293424)
113. Jiang, H., Wang, Z., Serra, D., et al. (2004). Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies. Mol. Ther. 10, 1140-1142. (Pubitemid 39625257)
114. Jin, T., Perry, A., Jiang, J., et al. (2012). Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36, 561-571.
115. Jogler, C., Hoffmann, D., Theegarten, D., et al. (2006). Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J. Virol. 80, 3549-3558.
116. Jurgeit, A., Mcdowell, R., Moese, S., et al. (2012). Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 8, e1002976.
117. Kaiser, W.J., Upton, J.W., and Mocarski, E.S. (2013). Viral modulation of programmed necrosis. Curr. Opin. Virol. 3, 296-306.
118. Kalin, S., Amstutz, B., Gastaldelli, M., et al. (2010). Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J. Virol. 84, 5336-5350.
119. Kalvakolanu, D.V., Bandyopadhyay, S.K., Harter, M.L., et al. (1991). Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88, 7459-7463. (Pubitemid 21915171)
120. Kalyuzhniy, O., Di Paolo, N.C., Silvestry, M., et al. (2008). Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 105, 5483-5488. (Pubitemid 351753889)
121. Karen, K.A., and Hearing, P. (2011). Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J. Virol. 85, 4135-4142.
122. Kawai, T., and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650.
123. Khare, R., Chen, C.Y., Weaver, E.A., et al. (2011). Advances and future challenges in adenoviral vector pharmacology and targeting. Curr. Gene Ther. 11, 241-258.
124. Khare, R., Reddy, V.S., Nemerow, G.R., et al. (2012). Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J. Virol. 86, 2293-2301.
125. Khare, R., Hillestad, M.L., Xu, Z., et al. (2013). Circulating antibodies and macrophages as modulators of adenovirus pharmacology. J. Virol. 87, 3678-3686.
126. Kim, P.-H., Sohn, J.-H., Choi, J.-W., et al. (2011). Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin. Biomaterials 32, 2314-2326.
127. Kootstra, N.A., and Verma, I.M. (2003). Gene therapy with viral vectors. Annu. Rev. Pharmacol. Toxicol. 43, 413-439. (Pubitemid 37372648)
128. Kovesdi, I., and Hedley, S.J. (2010). Adenoviral producer cells. Viruses 2, 1681-1703.
129. Kreppel, F., and Kochanek, S. (2004). Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J. Virol. 78, 9-22. (Pubitemid 37549715)
130. Kwon, O.-J., Kang, E., Choi, J.-W., et al. (2013). Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy. J. Controlled Release 169, 257-265.
131. Lam, E., Stein, S., and Falck-Pedersen, E. (2014). Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J. Virol. 88, 974-981.
132. Lamkanfi, M., and Dixit, V.M. (2010). Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8, 44-54.
133. Laver, W.G., Wrigley, N.G., and Pereira, H.G. (1969). Removal of penton from particles of adenovirus type 2. Virology 39, 599-605.
134. Lehrer, R.I., and Lu, W. (2012). alpha-Defensins in human innate immunity. Immunol Rev. 245, 84-112.
135. Lenaerts, L., and Naesens, L. (2006). Antiviral therapy for adenovirus infections. Antiviral Res. 71, 172-180. (Pubitemid 44223761)
136. Leopold, P.L., Kreitzer, G., Miyazawa, N., et al. (2000). Dynein-and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum. Gene Ther. 11, 151-165. (Pubitemid 30044048)
137. Leppard, K.N., Emmott, E., Cortese, M.S., et al. (2009). Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis. J. Gen. Virol. 90, 95-104.
138. Levine, B., Mizushima, N., and Virgin, H.W. (2011). Autophagy in immunity and inflammation. Nature 469, 323-335.
139. Li, T., Diner, B.A., Chen, J., et al. (2012). Acetylation modulates cellular distribution and DNA sensing ability of interferoninducible protein IFI16. Proc. Natl. Acad. Sci. USA 109, 10558-10563.
140. Lichtenstein, D.L., and Wold, W.S. (2004). Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission. Cancer Gene Ther. 11, 819-829. (Pubitemid 39636349)
141. Lichtenstein, D.L., Toth, K., Doronin, K., et al. (2004). Functions and mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 23, 75-111. (Pubitemid 38121748)
142. Liu, H., Jin, L., Koh, S.B., et al. (2010). Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 329, 1038-1043.
143. Lusky, M. (2005). Good manufacturing practice production of adenoviral vectors for clinical trials. Hum. Gene Ther. 16, 281-291. (Pubitemid 40471888)
144. Lutschg, V., Boucke, K., Hemmi, S., et al. (2011). Chemotactic anti-viral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nat. Commun. 2, 391.
145. Lyons, M., Onion, D., Green, N.K., et al. (2006). Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol. Ther. 14, 118-128. (Pubitemid 44191831)
146. Ma, Y., and Mathews, M.B. (1996). Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. J. Virol. 70, 5083-5099. (Pubitemid 26240679)
147. Mabit, H., Nakano, M.Y., Prank, U., et al. (2002). Intact microtubules support adenovirus and herpes simplex virus infections. J. Virol. 76, 9962-9971. (Pubitemid 35006534)
148. Mahr, J.A., and Gooding, L.R. (1999). Immune evasion by adenoviruses. Immunol. Rev. 168, 121-130. (Pubitemid 29276677)
149. Maier, O., Marvin, S.A., Wodrich, H., et al. (2012). Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape. J. Virol. 86, 10821-10828.
150. Maillard, P.V., Ciaudo, C., Marchais, A., et al. (2013). Antiviral RNA interference in mammalian cells. Science 342, 235-238.
151. Mallery, D.L., Mcewan, W.A., Bidgood, S.R., et al. (2010). Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. USA 107, 19985-19990.
152. Matlin, K.S., Reggio, H., Helenius, A., et al. (1981). Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91, 601-613. (Pubitemid 12211148)
153. Mcewan, W.A., Tam, J.C., Watkinson, R.E., et al. (2013). Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14, 327-336.
154. Mcneish, I.A., Lopes, R., Bell, S.J., et al. (2005). Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. Exp. Cell Res. 302, 69-82. (Pubitemid 39485236)
155. Mcsharry, B.P., Burgert, H.G., Owen, D.P., et al. (2008). Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J. Virol. 82, 4585-4594. (Pubitemid 351563695)
156. Meier, O., Boucke, K., Hammer, S.V., et al. (2002). Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158, 1119-1131.
157. Meier, O., Gastaldelli, M., Boucke, K., et al. (2005). Early steps of clathrin-mediated endocytosis involved in phagosomal escape of Fcgamma receptor-targeted adenovirus. J. Virol. 79, 2604-2613. (Pubitemid 40204614)
158. Meissner, J.D., Hirsch, G.N., Larue, E.A., et al. (1997). Completion of the DNA sequence of mouse adenovirus type 1: sequence of E2B, L1, and L2 (18-51 map units). Virus Res. 51, 53-64. (Pubitemid 27394390)
159. Mercer, J., and Greber, U.F. (2013). Virus interactions with endocytic pathways in macrophages and dendritic cells. Trends Microbiol. 21, 380-388.
160. Minamitani, T., Iwakiri, D., and Takada, K. (2011). Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. J. Virol. 85, 4035-4040.
161. Misawa, T., Takahama, M., Kozaki, T., et al. (2013). Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14, 454-460.
162. Mizushima, N., Noda, T., Yoshimori, T., et al. (1998). A protein conjugation system essential for autophagy. Nature 395, 395-398. (Pubitemid 28450691)
163. Moore, M.L., Mckissic, E.L., Brown, C.C., et al. (2004). Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. J. Virol. 78, 5584-5590. (Pubitemid 38661645)
164. Munz, C. (2011). Macroautophagy during innate immune activation. Front. Microbiol. 2, 72.
165. Muruve, D.A., Petrilli, V., Zaiss, A.K., et al. (2008). The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107. (Pubitemid 351355095)
166. Nanda, A., Lynch, D.M., Goudsmit, J., et al. (2005). Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. J. Virol. 79, 14161-14168. (Pubitemid 41552714)
167. Nickel, W., and Rabouille, C. (2009). Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148-155.
168. Nociari, M., Ocheretina, O., Schoggins, J.W., et al. (2007). Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 81, 4145-4157. (Pubitemid 46586909)
169. Nociari, M., Ocheretina, O., Murphy, M., et al. (2009). Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. J. Virol. 83, 4081-4091.
170. O'riordan, C.R., Lachapelle, A., Delgado, C., et al. (1999). PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10, 1349-1358. (Pubitemid 29267589)
171. Orzalli, M.H., Deluca, N.A., and Knipe, D.M. (2012). Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. USA 109, E3008-E3017.
172. Osorio, F., and Reis E Sousa, C. (2011). Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34, 651-664.
173. Ostapchuk, P., and Hearing, P. (2003). Regulation of adenovirus packaging. Curr. Top. Microbiol. Immunol. 272, 165-185. (Pubitemid 36458328)
174. Othman, M., Labelle, A., Mazzetti, I., et al. (2007). Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 109, 2832-2839. (Pubitemid 46482078)
175. Pazgier, M., Hoover, D.M., Yang, D., et al. (2006). Human beta-defensins. Cell Mol. Life Sci. 63, 1294-1313.
176. Perez, L., and Carrasco, L. (1994). Involvement of the vacuolar H( + )-ATPase in animal virus entry. J. Gen. Virol. 75, 2595-2606. (Pubitemid 24303175)
177. Perreau, M., Guerin, M.C., Drouet, C., et al. (2007). Interactions between human plasma components and a xenogenic adenovirus vector: reduced immunogenicity during gene transfer. Mol Ther. 15, 1998-2007. (Pubitemid 350011740)
178. Pichlmair, A., and Reis E Sousa, C. (2007). Innate recognition of viruses. Immunity 27, 370-383. (Pubitemid 47418682)
179. Puntener, D., and Greber, U.F. (2009). DNA-tumor virus entry-from plasma membrane to the nucleus. Sem. Cell. Dev. Biol. 20, 631-642.
180. Rabinovich, G.A., and Toscano, M.A. (2009). Turning "sweet" on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9, 338-352.
181. Rademacher, C., Bru, T., Mcbride, R., et al. (2012). A Sigleclike sialic-acid-binding motif revealed in an adenovirus capsid protein. Glycobiology 22, 1086-1091.
182. Randow, F., and Munz, C. (2012). Autophagy in the regulation of pathogen replication and adaptive immunity. Trends Immunol. 33, 475-487.
183. Rathinam, V.A., and Fitzgerald, K.A. (2011). Cytosolic surveillance and antiviral immunity. Curr. Opin. Virol. 1, 455-462.
184. Raty, J.K., Lesch, H.P., Wirth, T., et al. (2008). Improving safety of gene therapy. Curr. Drug. Saf. 3, 46-53. (Pubitemid 351223153)
185. Reddy, V.S., Natchiar, S.K., Stewart, P.L., et al. (2010). Crystal structure of human adenovirus at 3.5 A resolution. Science 329, 1071-1075.
186. Rein, D.T., Breidenbach, M., and Curiel, D.T. (2006). Current developments in adenovirus-based cancer gene therapy. Future Oncol. 2, 137-143.
187. Rodriguez-Rocha, H., Gomez-Gutierrez, J.G., Garcia-Garcia, A., et al. (2011). Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 416, 9-15.
188. Russell, S.J., Peng, K.W., and Bell, J.C. (2012). Oncolytic virotherapy. Nat. Biotechnol. 30, 658-670.
189. Ryter, S.W., and Choi, A.M. (2010). Autophagy in the lung. Proc. Am. Thorac. Soc. 7, 13-21.
190. Sabbatini, P., Chiou, S.K., Rao, L., et al. (1995). Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell Biol. 15, 1060-1070.
191. Saitoh, T., Fujita, N., Hayashi, T., et al. (2009). Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. USA 106, 20842-20846.
192. Salinas, S., Bilsland, L.G., Henaff, D., et al. (2009). CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog. 5, e1000442.
193. Sato,S., St-Pierre,C.,Bhaumik,P., et al. (2009).Galectins in innate immunity: dual functions of host soluble beta-galactosidebinding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol. Rev. 230, 172-187.
194. Schiedner, G., Bloch, W., Hertel, S., et al. (2003). A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells. Hum. Gene Ther. 14, 1631-1641. (Pubitemid 37452873)
195. Schneider, D., Greb, C., Koch, A., et al. (2010). Trafficking of galectin-3 through endosomal organelles of polarized and non-polarized cells. Eur. J. Cell Biol. 89, 788-798.
196. Schoggins, J.W., and Randall, G. (2013). Lipids in innate antiviral defense. Cell Host Microbe 14, 379-385.
197. Schreiner, S., Wimmer, P., Sirma, H., et al. (2010). Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J. Virol. 84, 7029-7038.
198. Schreiner, S., Martinez, R., Groitl, P., et al. (2012). Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog. 8, e1002549.
199. Schreiner, S., Burck, C., Glass, M., et al. (2013a). Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res. 41, 3532-3550.
200. Schreiner, S., Kinkley, S., Burck, C., et al. (2013b). SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection. PLoS Pathog. 9, e1003775.
201. Schulte, M., Sorkin, M., Al-Benna, S., et al. (2013). Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5. Springerplus 2, 234.
202. Seelenmeyer, C., Wegehingel, S., Tews, I., et al. (2005). Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J. Cell Biol. 171, 373-381. (Pubitemid 41540028)
203. Selsted, M.E., and Ouellette, A.J. (2005). Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6, 551-557. (Pubitemid 41710724)
204. Seth, P., Pastan, I., and Willingham, M.C. (1987). Adenovirusdependent changes in cell membrane permeability: role of Na +, K+-ATPase. J. Virol. 61, 883-888. (Pubitemid 17040219)
205. Shah, A.H., Cianciola, N.L., Mills, J.L., et al. (2007). Adenovirus RIDalpha regulates endosome maturation by mimicking GTP-Rab7. J. Cell Biol. 179, 965-980. (Pubitemid 350223492)
206. Shayakhmetov, D.M., Gaggar, A., Ni, S., et al. (2005). Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79, 7478-7491. (Pubitemid 40756784)
207. Sirena, D., Lilienfeld, B., Eisenhut, M., et al. (2004). The human membrane cofactor CD46 is a receptor for species B Adenovirus serotype 3. J. Virol. 78, 4454-4462. (Pubitemid 38501065)
208. Skevaki, C.L., Galani, I.E., Pararas, M.V., et al. (2011). Treatment of viral conjunctivitis with antiviral drugs. Drugs 71, 331-347.
209. Smith, J.G., and Nemerow, G.R. (2008). Mechanism of adenovirus neutralization by human alpha-defensins. Cell Host Microbe 3, 11-19.
210. Smith, J.G., Silvestry, M., Lindert, S., et al. (2010a). Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog. 6, e1000959.
211. Smith, J.G., Wiethoff, C.M., Stewart, P.L., et al. (2010b). Adenovirus. Curr. Top. Microbiol. Immunol. 343, 195-224.
212. Snijder, J., Reddy, V.S., May, E.R., et al. (2013). Integrin and defensin modulate the mechanical properties of adenovirus. J. Virol. 87, 2756-2766.
213. Sollerbrant, K., Akusjarvi, G., and Svensson, C. (1993). Repression of RNA polymerase III transcription by adenovirus E1A. J. Virol. 67, 4195-4204. (Pubitemid 23180746)
214. Stein, S.C., and Falck-Pedersen, E. (2012). Sensing adenovirus infection: activation of interferon regulatory factor 3 in RAW 264.7 cells. J. Virol. 86, 4527-4537.
215. Stein, S.C., Lam, E., and Falck-Pedersen, E. (2012). Cellspecific regulation of nucleic acid sensor cascades: a controlling interest in the antiviral response. J. Virol. 86, 13303-13312.
216. Steinstraesser, L., Sorkin, M., Jacobsen, F., et al. (2011). Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery. BMC Immunol. 12, 8.
217. Stilwell, J.L., Mccarty, D.M., Negishi, A., et al. (2003). Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression. J. Virol. 77, 12881-12885. (Pubitemid 37430682)
218. Stone, D., Liu, Y., Shayakhmetov, D., et al. (2007). Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J. Virol. 81, 4866-4871. (Pubitemid 46668683)
219. Stracker, T.H., Carson, C.T., and Weitzman, M.D. (2002). Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418, 348-352. (Pubitemid 34790688)
220. Stracker, T.H., Lee, D.V., Carson, C.T., et al. (2005). Serotypespecific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J. Virol. 79, 6664-6673. (Pubitemid 40677297)
221. Strunze, S., Trotman, L.C., Boucke, K., et al. (2005). Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol. Biol. Cell 16, 2999-3009. (Pubitemid 40741242)
222. Strunze, S., Engelke, M.F., Wang, I.-H., et al. (2011). Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection. Cell Host Microbe 10, 210-223.
223. Sun, L., Wu, J., Du, F., et al. (2013). Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791.
224. Suomalainen, M., and Greber, U.F. (2013). Uncoating of nonenveloped viruses. Curr. Opin. Virol. 3, 27-33.
225. Suomalainen, M., Nakano, M.Y., Boucke, K., et al. (1999). Microtubule-dependent minus and plus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144, 657-672. (Pubitemid 29234545)
226. Suomalainen, M., Nakano, M.Y., Boucke, K., et al. (2001). Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 20, 1310-1319. (Pubitemid 32233971)
227. Suomalainen, M., Luisoni, S., Boucke, K., et al. (2013). A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J. Virol. 87, 12367-12379.
228. Takeda, K., and Akira, S. (2004). TLR signaling pathways. Semin. Immunol. 16, 3-9. (Pubitemid 38147427)
229. Tanaka, Y., and Chen, Z.J. (2012). STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5, ra20.
230. Teodoro, J.G., and Branton, P.E. (1997). Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J. Virol. 71, 3620-3627. (Pubitemid 27172373)
231. Thompson, M.R., Kaminski, J.J., Kurt-Jones, E.A., et al. (2011). Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920-940.
232. Tian, J., Xu, Z., Smith, J.S., et al. (2009). Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. J. Virol. 83, 5648-5658.
233. Tibbles, L.A., Spurrell, J.C.L., Bowen, G.P., et al. (2002). Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J. Virol. 76, 1559-1568. (Pubitemid 34094602)
234. Toth, K., Dhar, D., and Wold, W.S. (2010). Oncolytic (replication- competent) adenoviruses as anticancer agents. Expert. Opin. Biol. Ther. 10, 353-368.
235. Trinh, H.V., Lesage, G., Chennamparampil, V., et al. (2012). Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J. Virol. 86, 1623-1637.
236. Trinh, H.V., Grossmann, J., Gehrig, P., et al. (2013). iTRAQbased and label-free proteomics approaches for studies of human adenovirus infections. Int. J. Proteomics 2013, 581862.
237. Trotman, L.C., Mosberger, N., Fornerod, M., et al. (2001). Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3, 1092-1100. (Pubitemid 33130460)
238. Trotman, L.C., Achermann, D.P., Keller, S., et al. (2003). Nonclassical export of an adenovirus structural protein. Traffic 4, 390-402. (Pubitemid 36656487)
239. Tschopp, J., Martinon, F., and Burns, K. (2003). NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4, 95-104. (Pubitemid 36172693)
240. Tuladhar, E., Bouwknegt, M., Zwietering, M.H., et al. (2012). Thermal stability of structurally different viruses with proven or potential relevance to food safety. J. Appl. Microbiol. 112, 1050-1057.
241. Ullman, A.J., and Hearing, P. (2008). Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J. Virol. 82, 7325-7335. (Pubitemid 352031201)
242. Ullman, A.J., Reich, N.C., and Hearing, P. (2007). Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J. Virol. 81, 4744-4752. (Pubitemid 46668671)
243. Unterholzner, L., Keating, S.E., Baran, M., et al. (2010). IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997-1004.
244. Vaysburd, M., Watkinson, R.E., Cooper, H., et al. (2013). Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proc. Natl. Acad. Sci. USA 110, 12397-12401.
245. Vigant, F., Descamps, D., Jullienne, B., et al. (2008). Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver. Mol. Ther. 16, 1474-1480.
246. Vogels, R., Zuijdgeest, D., Van Rijnsoever, R., et al. (2003). Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77, 8263-8271. (Pubitemid 36871454)
247. Vrijsen, R., Mosser, A., and Boeye, A. (1993). Postabsorption neutralization of poliovirus. J. Virol. 67, 3126-3133.
248. Waddington, S.N., Mcvey, J.H., Bhella, D., et al. (2008). Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132, 397-409. (Pubitemid 351200513)
249. Walters, R.W., Freimuth, P., Moninger, T.O., et al. (2002). Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110, 789-799. (Pubitemid 35283966)
250. Wang, K., Huang, S., Kapoor-Munshi, A., et al. (1998). Adenovirus internalization and infection require dynamin. J. Virol. 72, 3455-3458. (Pubitemid 28175599)
251. Wang, H., Li, Z.Y., Liu, Y., et al. (2011). Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17, 96-104.
252. Wang, I.H., Suomalainen, M., Andriasyan, V., et al. (2013). Tracking viral genomes in host cells at single-molecule resolution. Cell Host Microbe 14, 468-480.
253. Watkinson, R.E., Tam, J.C., Vaysburd, M.J., et al. (2013). Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21. J. Virol. 87, 7309-7313.
254. Weber, M., Gawanbacht, A., Habjan, M., et al. (2013). Incoming RNA virus nucleocapsids containing a 5¢-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 13, 336-346.
255. Weinberg, J.B., Stempfle, G.S., Wilkinson, J.E., et al. (2005). Acute respiratory infection with mouse adenovirus type 1. Virology 340, 245-254. (Pubitemid 41317498)
256. Weitzman, M.D. (2005). Functions of the adenovirus E4 proteins and their impact on viral vectors. Front. Biosci. 10, 1106-1117.
257. Weitzman, M.D., and Ornelles, D.A. (2005). Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 24, 7686-7696. (Pubitemid 41670671)
258. Weitzman, M.D., Lilley, C.E., and Chaurushiya, M.S. (2010). Genomes in conflict: maintaining genome integrity during virus infection. Annu. Rev. Microbiol. 64, 61-81.
259. White, E. (1993). Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc. Soc. Exp. Biol. Med. 204, 30-39. (Pubitemid 23274052)
260. Wiethoff, C.M., Wodrich, H., Gerace, L., et al. (2005). Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79, 1992-2000. (Pubitemid 40204556)
261. Wilson, S.S., Wiens, M.E., and Smith, J.G. (2013). Antiviral mechanisms of human defensins. J. Mol. Biol. 425, 4965-4980.
262. Windheim, M., Southcombe, J.H., Kremmer, E., et al. (2013). A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions. Proc. Natl. Acad. Sci. USA 110, E4884-E4893.
263. Wisnivesky, J.P., Leopold, P.L., and Crystal, R.G. (1999). Specific binding of the adenovirus capsid to the nuclear envelope. Hum. Gene Ther. 10, 2187-2195. (Pubitemid 29416298)
264. Wodrich, H., Henaff, D., Jammart, B., et al. (2010). A capsidencoded PPxY-motif facilitates adenovirus entry. PLoS Pathog. 6, e1000808.
265. Wohlfart, C. (1988). Neutralization of adenoviruses: kinetics, stoichiometry and mechanism. J. Virol. 62, 2321-2328.
266. Wold, W.S., Doronin, K., Toth, K., et al. (1999). Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr. Opin. Immunol. 11, 380-386. (Pubitemid 29377903)
267. Wolfrum, N., and Greber, U.F. (2013). Adenovirus signalling in entry. Cell. Microbiol. 15, 53-62.
268. Wong, H.H., Lemoine, N.R., and Wang, Y. (2010). Oncolytic viruses for cancer therapy: overcoming the obstacles. Viruses 2, 78-106.
269. Wonganan, P., Clemens, C.C., Brasky, K., et al. (2011). Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus. Mol. Pharmaceutics 8, 78-92.
270. Xiao, T.S., and Fitzgerald, K.A. (2013). The cGAS-STING pathway for DNA sensing. Mol. Cell 51, 135-139.
271. Xu, Z., Qiu, Q., Tian, J., et al. (2013). Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat. Med. 19, 452-457.
272. Yakimovich, A., Gumpert, H., Burckhardt, C.J., et al. (2012). Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model. J. Virol. 86, 10123-10137.
273. Yamamoto, M., and Curiel, D.T. (2010). Current issues and future directions of oncolytic adenoviruses. Mol. Ther. 18, 243-250.
274. Yan, N., and Chen, Z.J. (2012). Intrinsic antiviral immunity. Nat. Immunol. 13, 214-222.
275. Yang, Z., and Klionsky, D.J. (2010). Eaten alive: a history of macroautophagy. Nat. Cell Biol. 12, 814-822.
276. Zeng, X., and Carlin, C.R. (2013). Host cell autophagy modulates early stages of adenovirus infections in airway epithelial cells. J. Virol. 87, 2307-2319.
277. Zhang, Z., Yuan, B., Bao, M., et al. (2011). The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959-965.
278. Zhang, X., Shi, H., Wu, J., et al. (2013). Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell. 51, 226-235.
279. Zhao, H., Boije, H., Granberg, F., et al. (2009). Activation of the interferon-induced STAT pathway during an adenovirus type 12 infection. Virology 392, 186-195.
280. Zhong, B., Zhang, L., Lei, C., et al. (2009). The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397-407.
281. Zhu, J., Huang, X., and Yang, Y. (2007). Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. J. Virol. 81, 3170-3180. (Pubitemid 46456626)